Acceleron Pharma (XLRN) News Today → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free XLRN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative February 27, 2024 | benzinga.comORBIMED CAPITAL GP II LLC's Net WorthOctober 20, 2023 | investing.comXLRN Historical DataApril 15, 2023 | thestreet.comBrexit Bargain Buys: 14 More Stocks Picked by Morgan StanleyMarch 17, 2023 | reuters.comAstellas Pharma IncDecember 14, 2022 | finance.yahoo.comAcceleron Corp Becomes a Digital Correspondent BankNovember 30, 2022 | finance.yahoo.comPharma Contract Sales Market Report 2022-2032November 21, 2022 | reuters.comMerck to buy Imago for $1.35 bln to broaden portfolio of blood disorder drugsOctober 10, 2022 | msn.comCentre Piece Of Merck's $11.5B Acceleron Buyout Aces Late-Stage Cardiovascular TrialMay 23, 2022 | seekingalpha.comLiquidia slumps as United, MannKind get FDA nod for rival therapyJanuary 20, 2022 | thestreet.com19 Charts to Calm Your Recession FearsDecember 22, 2021 | finance.yahoo.comXLRN May 2022 140.000 putNovember 22, 2021 | finance.yahoo.comMerck Closes Biggest Biotech Deal of the YearNovember 22, 2021 | seekingalpha.comMerck announces completion of Acceleron Pharma acquisitionNovember 22, 2021 | marketbeat.comTrading was temporarily halted for "XLRN" at 07:11 PM with a stated reason of "News pending."November 21, 2021 | nasdaq.comMerck's (NYSE:MRK) Balance Sheet Can Easily Handle Acquisitions like Acceleron Pharma (NASDAQ: XLRN)November 17, 2021 | apnews.comAvoro Capital Urges Acceleron Shareholders Not to Tender Into Merck’s Inadequate OfferNovember 17, 2021 | nasdaq.comNotable Wednesday Option Activity: XLRN, LOW, ZGNXNovember 17, 2021 | finance.yahoo.comMerck Announces Expiration of Hart-Scott-Rodino Act Waiting Period and Extension of Tender Offer to Acquire Acceleron Pharma Inc.November 17, 2021 | seekingalpha.comMerck says HSR waiting period for Acceleron Pharma deal expiresNovember 15, 2021 | gurufocus.comAvoro Capital Advisors LLC Buys Acceleron Pharma Inc, Apellis Pharmaceuticals Inc, Aadi ...November 15, 2021 | gurufocus.comWestern Standard LLC Buys IHS Markit, Acceleron Pharma Inc, Marlin Business Services Corp, ...November 12, 2021 | finance.yahoo.comSome Acceleron Investors Want a Better Deal From MerckNovember 12, 2021 | msn.comIs Merck's Planned Acquisition of Acceleron in Trouble?November 9, 2021 | finance.yahoo.comAvoro Capital Releases Presentation Detailing Why Acceleron Shareholders Should Not Tender Into Merck’s Inadequate OfferNovember 4, 2021 | chron.comAcceleron: Q3 Earnings SnapshotNovember 4, 2021 | finance.yahoo.comAcceleron Reports Third Quarter 2021 Financial ResultsNovember 3, 2021 | finance.yahoo.comWhy Earnings Season Could Be Great for Acceleron Pharma (XLRN)November 2, 2021 | finance.yahoo.comNOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Acceleron Pharma Inc. (Nasdaq - XLRN), Kraton Corporation (NYSE - KRA), Dawson Geophysical Company (Nasdaq – DWSN)November 2, 2021 | finance.yahoo.comFarallon Capital Opposes Terms of Merck’s Acceleron TakeoverNovember 1, 2021 | finance.yahoo.comMerck Pushes Acceleron Buyout By Refiling For Antitrust ReviewOctober 30, 2021 | finance.yahoo.comMerck to Refile Notification of Acceleron Merger Deal, Extending Deadline for ShareholdersOctober 28, 2021 | law360.comAvoro Capital Slams Merck's $11.5B Acceleron DealOctober 28, 2021 | finance.yahoo.comEarnings Preview: Acceleron Pharma (XLRN) Q3 Earnings Expected to DeclineOctober 28, 2021 | finance.yahoo.comSHAREHOLDER NOTICE: Brodsky & Smith Continues an Investigation of Acceleron Pharma Inc. (Nasdaq - XLRN)October 28, 2021 | finance.yahoo.comAvoro Capital Issues Open Letter to Fellow Acceleron Pharma ShareholdersOctober 27, 2021 | finance.yahoo.comAcceleron Announces Third Quarter 2021 REBLOZYL® Net SalesOctober 25, 2021 | finance.yahoo.comMerck (MRK) to Report Q3 Earnings: What's in the Cards?October 21, 2021 | finance.yahoo.comBristol-Myers Plans to Exit Acceleron Stake With Merck DealOctober 18, 2021 | finance.yahoo.comACCELERON PHARMA ALERT: Investors Should Contact Bragar Eagel & Squire, P.C. Over Tender Offer for XLRN SharesOctober 15, 2021 | finance.yahoo.com(XLRN): Johnson Fistel Investigates Proposed Sale of Acceleron Pharma; Is $180 a Fair Price?October 13, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Acceleron Pharma Inc. - XLRNOctober 13, 2021 | financialpost.comHolocene Advisors says Merck’s offer undervalues AcceleronOctober 12, 2021 | finance.yahoo.comMerck Begins Tender Offer to Acquire Acceleron Pharma Inc.October 9, 2021 | finance.yahoo.com3 Reasons to Buy Merck Stock Right NowOctober 8, 2021 | msn.comIs an Acquisition of Acceleron a Smart Move for Merck?October 7, 2021 | finance.yahoo.comNOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Acceleron Pharma Inc. (NASDAQ:XLRN), Sanderson Farms, Inc. (NASDAQ:SAFM), JMP Group LLC (NYSE:JMP)October 6, 2021 | finance.yahoo.comMERGER ALERT - TGP, XLRN, and VNE: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these CompaniesOctober 4, 2021 | markets.businessinsider.comWhere Acceleron Pharma Stands With AnalystsOctober 4, 2021 | forbes.comWith Acceleron Acquisition Merck Stock Is Likely To See A Multiple RevisionOctober 2, 2021 | businesswire.comACCELERON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acceleron Pharma Inc ... Get Acceleron Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XLRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now XLRN Media Mentions By Week XLRN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XLRN News Sentiment▼0.000.76▲Average Medical News Sentiment XLRN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XLRN Articles This Week▼00▲XLRN Articles Average Week Get Acceleron Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XLRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADPT News Today KOD News Today BIIB News Today BNTX News Today ARGX News Today NBIX News Today TECH News Today QGEN News Today RGEN News Today PCVX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XLRN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsLEAKED: Jeff Bezos' $330 Million GambleBehind the MarketsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acceleron Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
